Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    Pavlova, A., Delev, D., Lacroix-Desmazes, S., Schwaab, R., Mende, M., Fimmers, R., Jan Astermark & Oldenburg, J., 2009, In : Journal of Thrombosis and Haemostasis. 7, 12, p. 2006-2015

    Research output: Contribution to journalArticle

  2. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 2216-2223

    Research output: Contribution to journalArticle

  3. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies

    Eliasson, A., Bergqvist, D., Bjorck, M., Stefan Acosta, Sternby, N. & Ogren, M., 2006, In : Journal of Thrombosis and Haemostasis. 4, 9, p. 1897-1902

    Research output: Contribution to journalArticle

  4. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, In : Journal of Thrombosis and Haemostasis. 9, 12, p. 2447-2456

    Research output: Contribution to journalArticle

  5. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 971-973

    Research output: Contribution to journalLetter

  6. Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects

    Krabbe, KS., Bruunsgaard, H., Andreas Hillarp & Thorsen, S., 2006, In : Journal of Thrombosis and Haemostasis. 4, 3, p. 692-694

    Research output: Contribution to journalLetter

  7. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R. D., J. Astermark, Male, C., Peerlinck, K., le Cessie, S., Van der Bom, J. G. & Fijnvandraat, K., 2017 Jul 3, In : Journal of Thrombosis and Haemostasis. 15, 7, p. 1422-1429

    Research output: Contribution to journalArticle

  8. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Eikenboom, J., Van Marion, V., Putter, H., Goodeve, A., Rodeghiero, F., Castaman, G., Federici, AB., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 othersPeake, I., 2006, In : Journal of Thrombosis and Haemostasis. 4, 4, p. 774-782

    Research output: Contribution to journalArticle

  9. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?

    Lindqvist, P. G. & Juan Merlo, 2005, In : Journal of Thrombosis and Haemostasis. 3, 2, p. 221-223

    Research output: Contribution to journalLetter

  10. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  11. Molecular recognition in the protein C anticoagulant pathway.

    Björn Dahlbäck & Villoutreix, B. O., 2003, In : Journal of Thrombosis and Haemostasis. 1, 7, p. 1525-1534

    Research output: Contribution to journalArticle

  12. Monitoring the bioavailability of FEIBA with a thrombin generation assay

    Varadi, K., Negrier, C., Erik Berntorp, Jan Astermark, Bordet, JC., Morfini, M., Linari, S., Schwarz, HP. & Turecek, PL., 2003, In : Journal of Thrombosis and Haemostasis. 1, 11, p. 2374-2380

    Research output: Contribution to journalArticle

  13. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, In : Journal of Thrombosis and Haemostasis. 10, 2, p. 217-222

    Research output: Contribution to journalArticle

  14. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, In : Journal of Thrombosis and Haemostasis. 10, 12, p. 2503-2511

    Research output: Contribution to journalArticle

  15. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, In : Journal of Thrombosis and Haemostasis. 11, 11, p. 2001-2008

    Research output: Contribution to journalArticle

  16. Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

    Goudemand, J., Scharrer, I., Erik Berntorp, Lee, CA., Borel-Derlon, A., Stieltjes, N., Caron, C., Scherrmann, JM., Bridey, F., Tellier, Z., Federici, AB. & Mannucci, PM., 2005, In : Journal of Thrombosis and Haemostasis. 3, 10, p. 2219-2227

    Research output: Contribution to journalArticle

  17. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, In : Journal of Thrombosis and Haemostasis. 5, 2, p. 263-265

    Research output: Contribution to journalArticle

  18. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  19. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  20. Post-translational modifications in proteins involved in blood coagulation.

    Hansson, K. M. & Johan Stenflo, 2005, In : Journal of Thrombosis and Haemostasis. 3, 12, p. 2633-2648

    Research output: Contribution to journalReview article

  21. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Hedner, U., 2006, In : Journal of Thrombosis and Haemostasis. 4, Aug 14, p. 2498-2500

    Research output: Contribution to journalArticle

  22. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  23. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    Tuckuviene, R., Ranta, S., Albertsen, B. K., Andersson, N. G., Bendtsen, M. D., Frisk, T., Gunnes, M. W., Helgestad, J., Heyman, M. M., Jonsson, O. G., Mäkipernaa, A., Pruunsild, K., Ulf Tedgård, Trakymiene, S. S. & Ruud, E., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 485-494

    Research output: Contribution to journalArticle

  24. Prothrombin complex concentrate and effects on thecone and plate analyser

    Ulf Schött, Jirgård, L., Strandberg, K. & Hillarp, A., 2009, In : Journal of Thrombosis and Haemostasis. 7, s2, p. 885 1 p., PP-WE-758.

    Research output: Contribution to journalPublished meeting abstract

  25. Quantification of ADP and ATP receptor expression in human platelets.

    Wang, L., Ostberg, O., Anna-Karin Wihlborg, Brogren, H., Jern, S. & David Erlinge, 2003, In : Journal of Thrombosis and Haemostasis. 1, 2, p. 330-336

    Research output: Contribution to journalArticle

  26. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    Lauritzen, B., Hedner, U., Johansen, P. B., Tranholm, M. & Ezban, M., 2008, In : Journal of Thrombosis and Haemostasis. 6, 5, p. 804-811

    Research output: Contribution to journalArticle

  27. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  28. rFVIIa transported from the blood stream into tissues is functionally active

    Gopalakrishnan, R., Hedner, U., Clark, C., Pendurthi, U. R. & Rao, L. V. M., 2010, In : Journal of Thrombosis and Haemostasis. 8, 10, p. 2318-2321

    Research output: Contribution to journalLetter

  29. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

    Vossen, CY., Conard, J., Fontcuberta, J., Makris, M., Van der Meer, FJM., Pabinger, I., Palareti, G., Preston, FE., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2005, In : Journal of Thrombosis and Haemostasis. 3, 3, p. 459-464

    Research output: Contribution to journalArticle

  30. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 1191-1199

    Research output: Contribution to journalArticle

  31. Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes

    Odeberg, J., Freitag, M., Odeberg, H., Lennart Råstam & Lindblad, U., 2006, In : Journal of Thrombosis and Haemostasis. 4, 4, p. 909-912

    Research output: Contribution to journalLetter

  32. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.

    Öhlin, A-K., Larsson, K. & Hansson, M., 2005, In : Journal of Thrombosis and Haemostasis. 3, 5, p. 976-982

    Research output: Contribution to journalArticle

  33. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 361-372

    Research output: Contribution to journalArticle

  34. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, In : Journal of Thrombosis and Haemostasis. 5, 9, p. 1936-1944

    Research output: Contribution to journalArticle

  35. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    Marx, P. F., Plug, T., Havik, S. R., Mörgelin, M. & Meijers, J. C. M., 2009, In : Journal of Thrombosis and Haemostasis. 7, 3, p. 445-452

    Research output: Contribution to journalArticle

  36. The discovery of activated protein C resistance.

    Björn Dahlbäck, 2003, In : Journal of Thrombosis and Haemostasis. 1, 1, p. 3-9

    Research output: Contribution to journalArticle

  37. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

    Rodeghiero, F., Castaman, G., Tosetto, A., Batlle, J., Baudo, F., Cappelletti, A., Casana, P., De Bosch, N., Eikenboom, JCJ., Federici, AB., Lethagen, S., Linari, S. & Srivastava, A., 2005, In : Journal of Thrombosis and Haemostasis. 3, 12, p. 2619-2626

    Research output: Contribution to journalArticle

  38. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle

  39. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Kozarcanin, H., Lood, C., Munthe-Fog, L., Sandholm, K., Hamad, O. A., Anders Bengtsson, Skjoedt, M-O., Huber-Lang, M., Garred, P., Ekdahl, K. N. & Nilsson, B., 2016, In : Journal of Thrombosis and Haemostasis. 14, 3, p. 531-545

    Research output: Contribution to journalArticle